Genzyme, Cobrek End Kidney Drug Patent Fight
Genzyme Corp. and Cobrek Pharmaceuticals Inc. on Thursday agreed to end a suit in Illinois federal court in which Genzyme accused Cobrek of infringing a patent covering kidney disease treatment Hectorol...To view the full article, register now.
Already a subscriber? Click here to view full article